We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
-0.79%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$175M
AUM Growth
-$5.24M
(-2.9%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-61.2%
Top 10 Holdings %
Top 10 Hldgs %
71.4%
Holding
129
New
32
Increased
17
Reduced
29
Closed
29
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$2.18M |
| 2 |
Teladoc Health
TDOC
|
+$2.04M |
| 3 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$1.41M |
| 4 |
DNA X Inc
SONM
|
+$1.18M |
| 5 |
Nutanix
NTNX
|
+$1.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$2.53M |
| 2 |
DZSI
DZS Inc. Common Stock
DZSI
|
+$1.96M |
| 3 |
Booking.com
BKNG
|
+$1.47M |
| 4 |
Magnachip Semiconductor
MX
|
+$1.2M |
| 5 |
Micron Technology
MU
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Healthcare | 6.35% |
| 3 | Industrials | 1.7% |
| 4 | Consumer Discretionary | 0.17% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHMA
26
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $510K | 0.29% |
+103,227
| New | +$585K |
|
27
PUT
iShares S&P 100 ETF
OEF
$19.5B
| $504K | 0.29% |
100,000
+50,000
| +100% | +$6.55M |
|
28
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.7B
| $496K | 0.28% |
8,224
-4,862
| -37% | -$293K |
|
29
Vanguard Information Technology ETF
VGT
$133B
| $478K | 0.27% |
17,760
-8,040
| -31% | -$216K |
|
30
Rigel Pharmaceuticals
RIGL
$723M
| $469K | 0.27% |
25,069
+2,275
| +10% | +$47K |
|
31
RF Industries
RFIL
$116M
| $463K | 0.26% |
65,372
-11,200
| -15% | -$86.9K |
|
32
State Street SPDR S&P Biotech ETF
XBI
$10B
| $449K | 0.26% |
5,885
-3,306
| -36% | -$275K |
|
|
LJPC
33
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $434K | 0.25% |
49,300
+27,300
| +124% | +$258K |
|
|
FLNA
34
Filana Therapeutics
FLNA
$42M
| $431K | 0.25% |
359,621
+62,998
| +21% | +$80.9K |
|
35
Nokia
NOK
$46.9B
| $426K | 0.24% |
+84,000
| New | +$433K |
|
|
LUMO
36
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $419K | 0.24% |
29,297
-6,982
| -19% | -$102K |
|
37
Vuzix
VUZI
$178M
| $417K | 0.24% |
182,600
-36,000
| -16% | -$83K |
|
|
AKTS
38
DELISTED
Akoustis Technologies Inc
AKTS
| $414K | 0.24% |
+53,432
| New | +$351K |
|
|
39
DNA X Inc
SONM
$4.63M
| $406K | 0.23% |
+77
| New | +$1.18M |
|
|
ADMS
40
DELISTED
Adamas Pharmaceuticals
ADMS
| $396K | 0.23% |
77,384
-10,524
| -12% | -$65K |
|
41
Orion Energy Systems
OESX
$38.9M
| $368K | 0.21% |
12,939
-2,560
| -17% | -$73.1K |
|
42
Larimar Therapeutics
LRMR
$377M
| $338K | 0.19% |
38,204
+16,075
| +73% | +$176K |
|
43
A10 Networks
ATEN
$2.07B
| $316K | 0.18% |
+45,474
| New | +$327K |
|
|
44
Booking.com
BKNG
$156B
| $300K | 0.17% |
3,825
-19,000
| -83% | -$1.47M |
|
45
DiaMedica Therapeutics
DMAC
$341M
| $294K | 0.17% |
141,801
+9,287
| +7% | +$30K |
|
46
State Street Industrial Select Sector SPDR ETF
XLI
$32.2B
| $294K | 0.17% |
3,789
-5,325
| -58% | -$408K |
|
|
QUMU
47
DELISTED
Qumu Corp.
QUMU
| $284K | 0.16% |
87,159
-17,200
| -16% | -$60.4K |
|
48
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
| $274K | 0.16% |
9,775
-5,255
| -35% | -$145K |
|
49
Argan
AGX
$6.9B
| $240K | 0.14% |
3,343
| – | – |
|
|
ALIM
50
DELISTED
Alimera Sciences
ALIM
| $237K | 0.14% |
+27,944
| New | +$254K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Worth Venture Partners held 129 positions worth $175M, down 2.9% from $181M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Worth Venture Partners withdrew a net $107M in Q3 2019, closing 29 positions and reducing 29 holdings. Its most notable exit was Coherent Inc, an estimated $2.53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Worth Venture Partners opened a new position in Illumina worth $2.19M.
- Worth Venture Partners's largest Q3 2019 buy was Illumina: 7,402 shares worth $2.19M.
- Worth Venture Partners added most to La Jolla Pharmaceutical Company in Q3 2019, an estimated $258K increase.
- Worth Venture Partners's biggest Q3 2019 reduction was Booking.com, cutting an estimated $1.47M.
- Worth Venture Partners fully exited Coherent Inc in Q3 2019, selling an estimated $2.53M.
- Worth Venture Partners's ten largest holdings make up 71% of its $175M portfolio in Q3 2019.
- Worth Venture Partners opened 32 new positions and closed 29 in Q3 2019.
- Worth Venture Partners's portfolio value fell 2.9% quarter-over-quarter to $175M.
Based on Worth Venture Partners's 13F filing for Q3 2019, filed 12 Nov 2019.